• FDA OKs First 'Extended' Adjuvant Treatment for HER2 Breast Cancer

    10 days ago - By Medscape

    The FDA has approved a new drug for patients with early-stage HER2-positive breast cancer who have completed trastuzumab and want "extended" adjuvant therapy.
    FDA Approvals
    Read more ...

     

  • Neratinib Approved for Extended Adjuvant Breast Ca Treatment

    10 days ago - By MedPageToday

    Drug targets epidermal growth factor receptors HER2 and EGFR
    Read more ...